Literature DB >> 25575979

Successful radiation treatment of chylous ascites following pancreaticoduodenectomy.

Stefanie Corradini1, Sylke Liebig, Olivier M Niemoeller, Felix Zwicker, Wolfram Lamadé.   

Abstract

Chylous ascites is a rare complication following pancreaticoduodenectomy. We report on a case of chylous ascites following pancreaticoduodenectomy in a 76-year-old patient diagnosed with pancreatic cancer. There are various known conservative management strategies, including dietary measures or total parenteral nutrition. Unfortunately, conservative treatment-with total parenteral nutrition and fasting over a period of 4 weeks-was not successful in the present case. The daily output volume of chylous ascites was up to 2500 ml/day. Based on clinical experiences with successfully treated lymphocutaneous fistulas, low-dose radiotherapy was initiated. External beam radiotherapy comprising a total dose of 8.0 Gy to the paraaortic lymph node region was administered in daily single fractions of 1.0 Gy (five fractions/week). Throughout the course of external beam radiotherapy, the secretion of abdominal ascites rapidly decreased, resulting in complete resolution after 2 weeks. There was no clinical evidence of chylous ascites on follow-up. As a result of this experience, we believe that external beam radiotherapy should be considered as an alternative therapy in refractory cases of chylous ascites.

Entities:  

Mesh:

Year:  2015        PMID: 25575979     DOI: 10.1007/s00066-014-0805-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  15 in total

1.  Radiotherapeutic management of the chyloperitoneum following abdominal aortic aneurysm repair.

Authors:  Joaquín Pérez; José María Arribas; Enrique Cárdenas; Francisco Gutiérrez; Rubén Taboada; Norberto Cassinello
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2013-07-04

2.  Postoperative chemoradiotherapy following pancreaticoduodenectomy. Impact of dose-volumetric parameters on the development of diabetes mellitus.

Authors:  K Eom; E K Chie; K Kim; J J Jang; S W Kim; D Y Oh; S A Im; T Y Kim; Y J Bang; S W Ha
Journal:  Strahlenther Onkol       Date:  2013-08-03       Impact factor: 3.621

3.  Lymphatic fistulas: obliteration by low-dose radiotherapy.

Authors:  Ramona Mayer; Peter Sminia; William H McBride; Heidi Stranzl; Ulrike Prettenhofer; Johannes Fruhwirth; Johann Poschauko
Journal:  Strahlenther Onkol       Date:  2005-10       Impact factor: 3.621

4.  Chylous ascites after pancreaticoduodenectomy: introduction of a grading system.

Authors:  Niels A van der Gaag; Andries C Verhaar; Elizabeth B Haverkort; Olivier R C Busch; Thomas M van Gulik; Dirk J Gouma
Journal:  J Am Coll Surg       Date:  2008-08-23       Impact factor: 6.113

5.  Chylous ascites following para-aortic lymphadenectomy: a case report.

Authors:  Nurettin Boran; Aylin Pelin Cil; Gokhan Tulunay; Nejat Ozgul; M Faruk Kose
Journal:  Gynecol Oncol       Date:  2004-06       Impact factor: 5.482

6.  Chylous ascites after radical nephrectomy and inferior vena cava thrombectomy. Successful conservative management with somatostatin analogue.

Authors:  Ilan Leibovitch; Yoram Mor; Jacob Golomb; Jacob Ramon
Journal:  Eur Urol       Date:  2002-02       Impact factor: 20.096

7.  Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable prognosis.

Authors:  Akira Nakamura; Satoshi Itasaka; Kyoichi Takaori; Yoshiya Kawaguchi; Keiko Shibuya; Michio Yoshimura; Yukinori Matsuo; Takashi Mizowaki; Shinji Uemoto; Masahiro Hiraoka
Journal:  Strahlenther Onkol       Date:  2014-03-06       Impact factor: 3.621

8.  Pancreatic cancer with chylous ascites demonstrated by lymphoscintigraphy: successful treatment with peritoneovenous shunting.

Authors:  Hidetaka Wagayama; Tsuyoshi Tanaka; Makoto Shimomura; Katsufumi Ogura; Katsuya Shiraki
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

9.  Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer.

Authors:  Luciana Caravatta; Giuseppina Sallustio; Fabio Pacelli; Gilbert D A Padula; Francesco Deodato; Gabriella Macchia; Mariangela Massaccesi; Vincenzo Picardi; Savino Cilla; Alfonso Marinelli; Numa Cellini; Vincenzo Valentini; Alessio G Morganti
Journal:  Radiat Oncol       Date:  2012-06-12       Impact factor: 3.481

10.  Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer.

Authors:  Yeon-Joo Kim; Woo Jin Lee; Sang Myung Woo; Tae Hyun Kim; Sung-Sik Han; Bo Hyun Kim; Sung Ho Moon; Sang Soo Kim; Young Hwan Koh; Sang-Jae Park; Joo-Young Kim; Dae Yong Kim; Joong-Won Park
Journal:  Radiat Oncol       Date:  2013-07-03       Impact factor: 3.481

View more
  3 in total

1.  Successful treatment of refractory chylous ascites due to follicular lymphoma with very low-dose radiotherapy.

Authors:  Márcio Tavares; Sofia Ramalheira; Sérgio Chacim; Rui Henrique; Ângelo Oliveira; José Mário Mariz
Journal:  Rep Pract Oncol Radiother       Date:  2019-06-02

Review 2.  Incidence and risk factors for Chyle leak after pancreatic surgery for cancer: A comprehensive systematic review.

Authors:  Milena Muzzolini; Raphael L C Araujo; T Peter Kingham; Frédérique Peschaud; François Paye; Renato M Lupinacci
Journal:  Eur J Surg Oncol       Date:  2021-12-03       Impact factor: 4.424

3.  Low-dose radiation therapy for massive chylous leakage after subtotal gastrectomy.

Authors:  Sang-Won Kim; Jung Hoon Kim
Journal:  Radiat Oncol J       Date:  2017-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.